Clinical Outcomes of Arthroscopic Surgeries for Shoulder and Knee Sports Injuries
SK-COHORT
Clinical Outcomes and Associated Factors Following Arthroscopic Surgeries for Shoulder and Knee Sports Injuries: A Prospective Cohort Study
1 other identifier
observational
500
1 country
1
Brief Summary
This observational study aims to evaluate the long-term recovery and clinical outcomes of patients undergoing minimally invasive (arthroscopic) surgeries for sports-related shoulder and knee injuries. Sports injuries, such as ligament tears, meniscus damage, and rotator cuff tears, are common and can significantly impact a person's daily life and ability to return to sports. While surgery is an effective treatment, the recovery process and final outcomes can vary greatly from person to person. Researchers will follow patients who are already scheduled for routine shoulder or knee surgery at the study center. By collecting detailed information about the patient's initial injury, the specific surgical techniques used by the doctor, and the patient's recovery progress over two years, the study hopes to identify which factors lead to the best healing and functional outcomes. Participants will be asked to complete standard questionnaires about their joint function and pain levels before their surgery, and again at 6 months, 1 year, and 2 years after surgery. The study is strictly observational; it will not change the standard medical care, surgical plan, or rehabilitation routine the patients receive.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P75+ for all trials
Started Apr 2026
Longer than P75 for all trials
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
March 24, 2026
CompletedFirst Posted
Study publicly available on registry
March 30, 2026
CompletedStudy Start
First participant enrolled
April 7, 2026
CompletedPrimary Completion
Last participant's last visit for primary outcome
April 7, 2046
ExpectedStudy Completion
Last participant's last visit for all outcomes
April 7, 2046
April 13, 2026
March 1, 2026
20 years
March 24, 2026
April 7, 2026
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
Patient-Reported Outcome Measures (PROMs) for Joint Function
Validated questionnaires evaluate function, symptoms, and QoL based on the specific cohort. 1. Higher scores indicate better outcomes (better function / less symptoms): Score 0 to 100: IKDC, Pedi-IKDC, KOOS, ACL-RSI, WOMET, Kujala AKPS, BPII 2.0, ASES, Rowe score, and EQ-5D VAS. Score 0 to 48: OSIS (Oxford Shoulder Instability) and OSS (Oxford Shoulder). Score 0 to 10: Tegner Activity Scale (higher = higher activity level). Score 0 to 16: Marx Activity Scale (higher = higher activity level). 2. Lower scores indicate better outcomes (less pain / less disability): Score 0 to 10: VAS and NRS (for pain). Score 0 to 100: Quick-DASH (upper extremity disability).
Preoperative baseline, 2 weeks, 1 month, 6 months, 1 year, and 2 years postoperatively.
Secondary Outcomes (2)
Incidence of Postoperative Complications
From the date of surgery up to 2 years postoperatively.
Pain Intensity Assessed by Visual Analog Scale (VAS)
Preoperative baseline, 2 weeks, 1 month, 6 months, 1 year, and 2 years postoperatively.
Study Arms (2)
Shoulder Cohort
Patients diagnosed with sports-related shoulder injuries (e.g., rotator cuff tear, shoulder instability) who are scheduled to undergo elective, standard-of-care shoulder arthroscopic surgery.
Knee Cohort
Patients diagnosed with sports-related knee injuries (e.g., ACL rupture, meniscus tear) who are scheduled to undergo elective, standard-of-care knee arthroscopic surgery.
Interventions
Routine, minimally invasive arthroscopic surgical procedures tailored to the patient's specific shoulder pathology, followed by standard postoperative rehabilitation. This is strictly observational; no experimental procedures are introduced.
Routine, minimally invasive arthroscopic surgical procedures tailored to the patient's specific knee pathology, followed by standard postoperative rehabilitation. This is strictly observational; no experimental procedures are introduced.
Eligibility Criteria
The study population consists of consecutive real-world patients presenting to the sports medicine clinic or inpatient ward at the study center. These are patients who have been diagnosed with shoulder or knee joint pathologies and are scheduled to receive standard-of-care elective surgical treatments.
You may qualify if:
- Age \>= 8 years.
- No gender restrictions.
- Definitive diagnosis of shoulder or knee sports injuries or related joint conditions.
- Scheduled to undergo elective, standard-of-care surgery at the study center (procedures include but are not limited to: arthroscopic meniscus repair/meniscectomy, cartilage repair, cruciate ligament reconstruction, high tibial osteotomy \[HTO\], unicompartmental knee arthroplasty \[UKA\], arthroscopic rotator cuff repair, shoulder stabilization, and shoulder arthroplasty).
- Clear consciousness, with the ability to read, understand, and communicate.
- Willing and able to comply with postoperative follow-up requirements.
- Voluntarily signed the written informed consent form.
You may not qualify if:
- Patients requiring emergency surgery due to acute, severe trauma (e.g., open fractures, polytrauma).
- Coexisting severe neurological or psychiatric diseases, or cognitive impairment that prevents understanding of the informed consent or cooperation with follow-up.
- Patients in an involuntary state (e.g., under coercion).
- Refusal to sign the informed consent form or refusal to participate in the study.
- Currently participating in other interventional clinical trials that may confound or affect the clinical outcomes of this study.
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
The Second Affiliated Hospital of Zhejiang University School of Medicine
Hangzhou, Zhejiang, China
Biospecimen
Discarded intraoperative tissues (e.g., synovial fluid, synovial tissue, degenerative meniscus or tendon fragments) and residual routine perioperative blood samples (serum/plasma). These specimens will be retained strictly for histological evaluation, biochemical analysis, and protein/biomarker profiling (e.g., inflammatory cytokines). No DNA extraction or genetic testing will be performed.
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Officials
- STUDY CHAIR
Yan Xiong, Doctor
Department of Orthopedic Surgery, The Second Affiliated Hospital, Zhejiang University School of Medicine, Hangzhou, Zhejiang, China
- PRINCIPAL INVESTIGATOR
Weijun Li, Master
Department of Orthopedic Surgery, The Second Affiliated Hospital, Zhejiang University School of Medicine, Hangzhou, Zhejiang, China
Central Study Contacts
Study Design
- Study Type
- observational
- Observational Model
- COHORT
- Time Perspective
- PROSPECTIVE
- Target Duration
- 2 Years
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
March 24, 2026
First Posted
March 30, 2026
Study Start
April 7, 2026
Primary Completion (Estimated)
April 7, 2046
Study Completion (Estimated)
April 7, 2046
Last Updated
April 13, 2026
Record last verified: 2026-03
Data Sharing
- IPD Sharing
- Will not share
Individual participant data (IPD) will not be shared publicly in order to strictly protect patient privacy and confidentiality. This decision is in accordance with the regulations of our hospital's Institutional Review Board (IRB) and local data security laws. Only highly aggregated, de-identified statistical data will be presented and published in peer-reviewed academic journals.